Published Date : 07 Feb 20 | Views: 89 | Industry : Chemical & Material
Allergic Reactions are Likely to Hamper the Growth of the Muscle Building Segment
The application segment of the market is divided into Pharmaceutical, muscle building, supplements, cosmetics, and personal care, and Others. Glutamine is increasingly being used in health supplementary products to build mass. Howeverthese products might create allergic reactions, which is expected to hamper the growth of the muscle-building segment of the market.
The type segment of the Glutamine (Gln) market is classified into L-Glutamine and D-Glutamine.
The Asia-Pacific Region is Expected to Emerge As a Profitable Market
The market in the Asia Pacific region is predicted to flourish remarkably in the next 6-years as a result of growing awareness among the population about protein and other health supplements.
. North America is the largest producer of Glutamine (Gln) and the market here is expected to get benefits from high consumption of protein supplements.
Market Players are Keen to Enter into Agreements with Suppliers
Some of the leading companies functioning in the market are Kyowa Hakko Kirin, Ajinomoto, Daesang, Fufen, and Meihua. Manufacturers are intent on strengthening their distribution channels and are focusing on entering into new agreements with suppliers.
High Prices of Health Supplements Containing Glutamine (Gln) is Expected to Hamper the Growth of the Market
Wellness is assumed as a new luxury and to maintain a healthy lifestyle people are willing to shell out more money from their pockets. This increasing craze for fitness has been increasing the popularity of the various health supplements including glutamine and this is precisely creating a positive impact on the growth of the global Glutamine (Gln) market. However, the overall growth rate of the market is sluggish because of the skyrocketing prices of the glutamine containing health supplements.
For further information, check :
For further information, check :https://www.qyrconsulting.com/reports/glutamine-gln-market